Electronic Cigarettes May Help Pregnant Women Quit Smoking: Study

Nov.17.2022
Electronic Cigarettes May Help Pregnant Women Quit Smoking: Study
New research published in Nature suggests that e-cigarettes may be more effective than nicotine patches for pregnant women trying to quit smoking. No new safety concerns were identified.

A recent study published in the journal Nature by the US National Institute for Health and Care Excellence (NIHR) has found that for pregnant women attempting to quit smoking, electronic cigarettes may be more effective than nicotine patches. Furthermore, the study did not raise any new safety concerns regarding electronic cigarettes.


The National Institute of Health in the United States has advised pregnant women to quit smoking, as it may harm the developing fetus. However, many find this difficult. Current guidelines suggest nicotine products such as patches, gum, and oral sprays can provide assistance, but this research suggests pregnant women should also consider switching to e-cigarettes.


Smoking during pregnancy is dangerous for developing babies and can increase the risk of low birth weight, premature birth, and miscarriage.


The author stated that in this study, a similar number of pregnant women quit smoking, regardless of whether they used e-cigarettes or nicotine patches. When researchers observed only women who used the assigned treatment method (without using other products), the number of women who quit smoking using e-cigarettes was nearly twice that of women who quit using nicotine patches.


Both methods are safe. The only significant difference is that women who use electronic cigarettes are less likely to give birth to low birth weight infants (weighing less than 2,500 grams). Researchers suggest that this is likely due to a reduction in cigarette use from using electronic cigarettes.


The current NHS proposal suggests that vaping is much safer for women and their babies than continuing to smoke cigarettes.


The author points out that electronic cigarettes have been proven to be more effective than nicotine replacement therapy for non-pregnant individuals. An increasing number of pregnant women are turning to e-cigarettes to quit smoking. Prior to this study, it was unclear whether they were effective or safe during pregnancy.


A study has found that electronic cigarettes are as safe for pregnant women as nicotine patches, and may be more effective in helping women quit smoking.


Peter Hajek, the director of the Health and Lifestyle Research Unit at the Wolfson Institute of Preventive Medicine at Queen Mary University of London, commented on the study's findings, saying, "Electronic cigarettes appear to be more effective than nicotine patches in helping pregnant women quit smoking, and as a result, they also seem to lead to better pregnancy outcomes. Evidence-based advice provided to smokers has already included recommendations to switch to electronic cigarettes, among other choices. Such advice can now be extended to pregnant smokers.


John Waldron, policy manager at Action on Smoking and Health, stated that there is strong evidence to show that e-cigarettes can effectively help non-pregnant individuals quit smoking. This study confirms that the effectiveness of e-cigarettes in helping pregnant women quit smoking is almost double that of nicotine patches. They are also as safe as other nicotine replacement products.


In a recent study, some women reported that they stopped using electronic cigarettes out of concern for the potential harm they may cause, and resumed smoking instead. This misconception that smoking is safer than using electronic cigarettes is hindering efforts to use them as a tool to help pregnant women quit smoking. This research should reassure healthcare professionals and users that electronic cigarettes are both safe and effective for helping pregnant women quit smoking and should be recommended along with nicotine replacement therapy. Quitting smoking during pregnancy is the best decision for the health of both the mother and the baby.


Future research may focus on the effectiveness of e-cigarettes in preventing women from resuming smoking after giving birth.


As a member of the public, Angela King stated, "As a former smoker (with no experience of smoking during pregnancy), I believe that the similarity between smoking and e-cigarette use may be significant. Placing a cigarette to your mouth is a part of the ritual, and I know people like me who have succumbed to e-cigarettes, finding it necessary to occupy our hands when experiencing cravings. This may give e-cigarettes an advantage over nicotine replacement therapy.


This study suggests that electronic cigarettes do not pose greater health risks than nicotine patches. Given the choice between patches and e-cigarettes, I suspect that more than a few pregnant women may opt for e-cigarettes.


Nicky Coote, a smoking cessation professional, added, "The results of this study seem reliable and it has a good methodology. However, short-acting products (oral sprays) were not combined with long-acting treatment (patches). This could result in women using products that are not assigned to them.


The study emphasizes the need to investigate the long-term effects of nicotine on developing infants, but it is clear that in many cases, e-cigarettes appear to be helpful. Compared to continuing tobacco use, they pose much less harm.


Statement:


This article is compiled from third-party information and is intended for industry professionals for the purpose of exchanging knowledge and ideas.


This article does not represent the opinion of 2FIRSTS and 2FIRSTS is unable to confirm the truthfulness or accuracy of the article's contents. The compilation of this article is only intended for industry exchange and research purposes.


Due to limitations in the level of translation, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong-Macau-Taiwan-related, or foreign-related statements and stances.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts held a U.S. compliance briefing in Shenzhen to help vaping, heated tobacco and nicotine pouch supply chain companies strengthen PMTA support capabilities. The event focused on supplier documentation, quality systems, traceability, TPMF/TPMP pathways, age verification and customer audit readiness as U.S. compliance expectations increasingly extend deeper into the nicotine supply chain.
Events
Jun.12
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA’s proposed rule requiring foreign tobacco manufacturers to register establishments and list products is more than routine paperwork, Keller and Heckman LLP partner Azim Chowdhury told 2Firsts. He said it could strengthen FDA’s import enforcement, inspections and market surveillance. Chinese e-cigarette OEM/ODM manufacturers, specification developers, brand owners and component suppliers may need to review their roles, product data and U.S. market authorization status.
Special Report
Jun.29
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Seoul city authorities inspected 339 tobacco vending machines at e-cigarette retailers and found that 168, or 49.5%, allowed purchases using fake IDs, showing that unmanned retail terminals and adult-verification systems remain a major enforcement gap after e-cigarettes were brought under tobacco regulation.
Market
Jul.03 by 2Firsts Perspectives
FIFA Bans Vaping in 2026 World Cup Stadiums, Putting Nicotine Rules in Event Compliance Focus
FIFA Bans Vaping in 2026 World Cup Stadiums, Putting Nicotine Rules in Event Compliance Focus
FIFA’s 2026 World Cup stadium rules prohibit smoking, vaping and the use of any tobacco products or electronic smoking devices inside stadiums, including inner and outer perimeters, while electronic smoking devices, tobacco products, lighters and matches are listed as prohibited items, bringing nicotine-product management, venue compliance and cross-border legal differences into focus at a major global sporting event.
Jul.06